>MNTA believes their version of Lovenox will be a de facto authorized generic, fully substitutable with Lovenox at the pharmacy level.<
If approved, automatic substitutability is a given because the filing is an ANDA rather than a 505b2. In other words, MNTA/Sandoz will be able to capture substantial market share without spending even a dime on marketing.
Market Data 
Markets 
AI
